Zucara signs licensing deal with CDRD for therapeutic drug candidate
Zucara Therapeutics has signed a licensing agreement with the Centre for Drug Research and Development (CDRD) for access to a patented set of therapeutic drug compounds that will define its lead drug candidate.
CDRD and Zucara are working in partnership to develop unique compounds that will lead to a new safe and effective long-term therapeutic approach as the first once-daily therapeutic to prevent hypoglycemia in patients with diabetes.
Click on this link for more information.
